TCL Archive NCI Boosts Funding For Cooperative Groups by $25 Million, Cuts Overall Accrual by 20 Percent, to 20,000 Patients November 11, 2011
TCL Archive EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor. December 15, 2000